Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major Depressive Disorder or Mild Cognitive Impairment
Recruiting now
Conditions studied: Mild Cognitive Impairment (MCI), Major Depressive Disorder, Remitted, Healthy Controls Group - Age and Sex-matched
In brief
The goal of this observational study is to validate the Creyos online cognitive assessment platform in individuals with mild cognitive impairment, or remitted major depressive disorder. The main objectives of this research are: 1. To confirm the feasibility of administering the Creyos cognitive battery to older adults with Mild Cognitive Impairment MCI) or Major Depressive Disorder in remission (rMDD). 2. To determine whether the Creyos battery can detect changes in cognition that are predictive of changes on paper-and-pencil neuropsychological testing ("gold standard") over up to five years. Participants will complete both in-person neuropsychological testing yearly as well as the Creyos online battery quarterly for up to 5 years, to allow us to compare performance on these two batteries over time.
Key facts
- Study ID
- NCT06780917
- Run by
- Centre for Addiction and Mental Health
- People needed
- 150
- Starts
- 2025-01-13
- Expected to finish
- 2029-01-01
- Last updated by the study team
- 2026-03-10
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- St. Michael's Hospital — Toronto, Ontario, Canada (enrolling)
- University Health Network — Toronto, Ontario, Canada (enrolling)
- Centre for Addiction and Mental Health — Toronto, Ontario, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.